Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat

NCT01808144 is registered in ClinicalTrials.gov with Ardea Biosciences, Inc. as lead sponsor.

NCT NCT01808144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Lead sponsor
Ardea Biosciences, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2013
Completion date
October 6, 2016
Enrollment
196 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

gout